Related Experiment Videos
Rejection and immunosuppression in kidney transplantation
Journal of Clinical & Laboratory Immunology
|November 1, 1979
Summary
Increased DNA synthesis in renal transplant patients often predicts rejection episodes before clinical signs appear. Monitoring DNA synthesis may help manage immunosuppression and prevent graft loss.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Renal allograft rejection is a major cause of graft loss.
- Early detection of rejection is crucial for effective immunosuppression management.
- Distinguishing rejection from infection is clinically important.
Purpose of the Study:
- To investigate the association between DNA synthesis and renal allograft rejection.
- To evaluate the predictive value of DNA synthesis for rejection episodes.
- To assess the role of DNA synthesis in differentiating rejection from infection.
Main Methods:
- Prospective monitoring of DNA synthesis in peripheral blood of renal allograft recipients.
- Correlation of DNA synthesis changes with clinical and biochemical markers of rejection and infection.
- Analysis of DNA synthesis patterns in patients experiencing rejection, graft loss, and infection.
Main Results:
- A significant increase in DNA synthesis was observed in 96% of rejection episodes, often preceding clinical signs by up to 7 days.
- Elevated DNA synthesis within 36 days of transplant was associated with irreversible rejection and graft loss.
- Increased DNA synthesis occurred in only 12.5% of infection episodes, suggesting a higher likelihood of rejection (8x) when DNA synthesis is elevated.
Conclusions:
- Increased peripheral blood DNA synthesis is a sensitive indicator of renal allograft rejection, preceding clinical manifestations.
- Monitoring DNA synthesis levels can aid in early detection of rejection and potentially prevent graft loss.
- DNA synthesis monitoring may help optimize immunosuppression levels and differentiate rejection from infection in renal transplant recipients.